Genenta Science S.p.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GNTA research report →
Price Chart
About the company
Genenta Science S. p. A.
- CEO
- Pierluigi Paracchi
- IPO
- 2021
- Employees
- 9
- HQ
- Milan, MI, IT
Get TickerSpark's AI analysis on GNTA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $17.98M
- P/E
- -1.63
- Fwd P/E
- 1.42
- PEG
- -0.05
- P/S
- 0.00
- P/B
- 0.52
- EV/EBITDA
- -4.79
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -36.82%
- ROIC
- -21.33%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-26,973+42.0%
- Op Income
- $-6,343,107
- Net Income
- $-6,272,111+32.6%
- EPS
- $-0.33+32.7%
- OCF Growth
- -10.1%
- FCF Growth
- -10.1%
- 52W High
- $2.58
- 52W Low
- $0.55
- 50D MA
- $0.75
- 200D MA
- $1.02
- Beta
- 0.77
- RSI (14)
- 48
- Avg Volume
- 86.02K
No earnings-call transcripts are available for GNTA yet.
- Free Float
- 76.0%
- Shares Outstanding
- 18.26M
- Float Shares
- 13.87M
of shares held by institutions
9 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Eurizon Capital Sgr S.P.A. | 360.00K | 0 |
| Allianz Se | 234.05K | 0 |
| Alti Global, Inc. | 200.29K | ▲ 200.29K |
| Citadel Advisors LLC | 190.95K | ▲ 190.95K |
| Bnp Paribas Financial Markets | 47.01K | ▲ 47.01K |
| Jane Street Group, LLC | 42.10K | ▲ 42.10K |
| Two Sigma Securities, LLC | 29.23K | ▲ 29.23K |
| Virtu Financial LLC | 26.58K | ▼ 10.33K |
| Xtx Topco Ltd | 20.48K | ▲ 20.48K |
| Ubs Group AG | 5.08K | ▲ 2.05K |
Our GNTA coverage
Recent articles, reports, and earnings notes.
No research on GNTA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GNTA report →Genenta Unveils Saentra Forge as Its New Brand, Advancing Its Transformation into a Strategic Industrial Platform
globenewswire.com · Nov 2
Genenta Science Announces Receipt of Nasdaq Minimum Bid Price Deficiency Notification
globenewswire.com · Oct 21
Sòphia High Tech Flight Hardware on Board VEGA-C VV30 as the European Launcher Carries Sentinel-3C and FLEX into Orbit
globenewswire.com · Sep 15
Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm
globenewswire.com · Jul 23
Genenta-Backed Sòphia High Tech Reports Fiscal Year 2025 Results
globenewswire.com · Jul 22
Genenta signs Definitive Agreements with Sophia High Tech
globenewswire.com · Apr 23
Genenta, evolving into Saentra Forge, has signed a Binding Offer with Sòphia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs
globenewswire.com · Mar 27
Genenta, evolving into Saentra Forge, continues to evaluate strategic options for its original biotechnology platform derived from the research of Professor Luigi Naldini
globenewswire.com · Mar 24
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.